Provided by Tiger Trade Technology Pte. Ltd.

Incyte

117.14
-4.2100-3.47%
Pre-market: 117.240.1000+0.09%08:37 EDT
Volume:2.36M
Turnover:279.69M
Market Cap:23.74B
PE:14.92
High:121.22
Open:120.47
Low:117.00
Close:121.35
52wk High:132.60
52wk Low:82.82
Shares:202.70M
Float Shares:169.82M
Volume Ratio:1.60
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.85
EPS(LYR):6.41
ROE:30.67%
ROA:16.83%
PB:3.74
PE(LYR):18.27

Loading ...

Incyte price target raised to $155 from $131 at Leerink

TIPRANKS
·
Aug 03

Incyte : Leerink Partners Raises Target Price to $155 from $131

THOMSON REUTERS
·
Aug 03

Incyte Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 01

Argus Adjusts Price Target on Incyte to $140 From $115, Maintains Buy Rating

MT Newswires Live
·
Jul 31

Earnings Beat: Incyte Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Simply Wall St.
·
Jul 31

JPMorgan Adjusts Price Target on Incyte to $120 From $110, Maintains Neutral Rating

MT Newswires Live
·
Jul 30

Amneal Q2 Revenue Beats on Specialty Segment Growth

Reuters
·
Jul 30

Incyte Corp. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 30

Corcept Therapeutics Q2 Revenue Estimates, Raises 2026 Outlook

Reuters
·
Jul 30

Incyte's Solid Q2 Seen Funding Strategy Beyond Jakafi Patent Expiration, RBC Says

MT Newswires Live
·
Jul 30

Incyte Analysts Raise Their Forecasts After Upbeat Q2 Results

Benzinga Earnings
·
Jul 29

Incyte Says Opzelura Cream Approved in EU to Treat Moderate Atopic Dermatitis

MT Newswires Live
·
Jul 29

Analysts’ Opinions Are Mixed on These Healthcare Stocks: GeoVax Labs (GOVX), Incyte (INCY) and Altimmune (ALT)

TIPRANKS
·
Jul 29

Incyte is Maintained at Overweight by Barclays

Dow Jones
·
Jul 29

Analysts Are Bullish on These Healthcare Stocks: Universal Health (UHS), Incyte (INCY)

TIPRANKS
·
Jul 29

Incyte : Morgan Stanley Raises Target Price to $119 from $104

THOMSON REUTERS
·
Jul 29

RBC Capital Sticks to Their Hold Rating for Incyte (INCY)

TIPRANKS
·
Jul 29

Incyte price target raised to $119 from $104 at Morgan Stanley

TIPRANKS
·
Jul 29

Incyte says EC approves Opzelura cream for treatment of AD

TIPRANKS
·
Jul 29

Incyte price target raised to $140 from $136 at BofA

TIPRANKS
·
Jul 29